Pharmex Group is a Spanish pharmaceutical company founded in August 2016 through the acquisition of the portfolio and the manufacturing plant of Laboratorios Pérez Giménez.

In 2018 Pharmex launched its products into the Spanish market and began its international expansion.

It is constituted by a Group World Headquarter in Switzerland, a Group Operational Headquarter in Madrid and a Manufacturing site based in Córdoba (Spain).

With a nutrition business unit, specialized in infant formulas, jars and cereals (Tebramil®), Pharmex aspires to be one of the leading providers in this field.

Pharmex is concentrating its efforts on the development, manufacturing and marketing of quality Rx, OTC and Medical Devices globally with strong emphasis in regions like Europe, MEA and LatAm.

Pharmex is focused on guaranteeing access to health with the highest quality standards based on the know-how of our technical staff and the vision and dynamism of our management team.

and future


Pharmex is committed to improving people’s health and well-being by providing health solutions directly or through strategic alliances.


To be a globally recognized company in the multipurpose manufacturing and commercialization of medicines and value-added pharmaceutical products that offer healthcare solutions to improve the quality of life of patients.

Pharmex Group around the world

Our values


Proactive and committed.
We deliver!


Diverse and humble.
We embrace difference.


Fast and efficient
We are ready for change.


We put our hearts
in achieving excellence.

Innovation and creation

Creative by definition.
We provide innovative solutions.

Improving lives worldwide through quality nutrition and greater access to innovative health services


Fill out the form below and we will respond as soon as possible

We inform you that PHARMEX uses the data obtained from the contact forms to resolve your queries, as well as to send information that can be considered of a commercial nature. The information that PHARMEX sends refers to what may be of interest to the recipient and at all times is related to PHARMEX products or services and for which the holder has shown some interest.

The legal basis for legality in the processing of data for this purpose is your consent to the consultation, as well as the legitimate interest of PHARMEX for the sending of information that could be considered commercial. Said legitimate interest is weighed by keeping you informed at all times of the possibility of unsubscribing from these shipments and by sending information always related to PHARMEX products and services, about which the holder was interested. These data will not be transferred in any case to third parties.

PHARMEX will keep your data as long as you do not object to its treatment.

Pharmacovigilance Unit

To report an adverse event or complaint contact or call: +34 689 009 866 including, in addition to full details of the adverse reaction, the following information:

– Patient details: Age, sex and country of occurrence.

– Details of the reporting person: Name, address, telephone/email, profession and date.

By sending your notification to you expressly agree that your data will be the responsibility of Pharmex. Your data will be used to analyze your case, follow up, notify the health authorities, and resolve your query. Your data will remain in Pharmex files until the resolution of the case and/or consultation.
You can exercise your rights of access, rectification, deletion, opposition, limitation of processing and portability.
For more information about the treatment of your data, please access Pharmex's privacy policy.